Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome

NCT00010400 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Systemic Lupus Erythematosus
Antiphospholipid Antibody Syndrome

Interventions

DRUG: Cyclophosphamide
DRUG: filgrastim

Sponsor

Johns Hopkins University